Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenue of $46.24M in the twelve months ending March 31, 2024, down -0.88% year-over-year. Revenue in the quarter ending March 31, 2024 was $13.79M with 13.68% year-over-year growth. In the year 2023, Recursion Pharmaceuticals had annual revenue of $44.58M with 11.88% growth.

• Revenue (ttm): $46.24M
• Revenue Growth: -0.88%
• P/S Ratio: 48.68
• Revenue / Employee: $92,470
• Employees: 500
• Market Cap: 2.25B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	44.58M	4.73M	11.88%
Dec 31, 2022	39.84M	29.67M	291.46%
Dec 31, 2021	10.18M	6.22M	156.89%
Dec 31, 2020	3.96M	1.64M	70.85%
Dec 31, 2019	2.32M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.